spec sheet12 rows
Zaleplon is a nonbenzodiazepine hypnotic of the pyrazolopyrimidine class, one of the so-called Z-drugs used for the short-term treatment of insomnia. It was approved in the United States in 1999 and is sold under brand names including Sonata. Because it has an unusually short duration of action, it is used mainly to help people fall asleep, including for awakenings in the middle of the night.
- Falls asleep faster
- Very short lasting so less morning grogginess
- Useful for middle of the night waking
- Little rebound insomnia
- Low next-day impairment at normal doses
- Next-day drowsiness and dizziness are possible, though usually less than with longer-acting sleeping pills
- Can cause complex sleep behaviors such as sleep-walking, sleep-eating, or sleep-driving
- Combining it with alcohol or other sedatives can cause dangerous over-sedation
- Regular use can lead to tolerance, dependence, and rebound insomnia on stopping
- Memory lapses and confusion can occur, particularly in older adults
Overview
Zaleplon is a sedative-hypnotic medication belonging to the nonbenzodiazepine, or Z-drug, group, and chemically it is a pyrazolopyrimidine [1]. It was developed and brought to market in the late 1990s, receiving approval from the US Food and Drug Administration in 1999, and it is marketed under names such as Sonata [1]. Like the related agents zolpidem and eszopiclone, zaleplon is chemically unrelated to benzodiazepines but produces broadly similar effects by acting on the same target [1].
The drug is prescribed for insomnia, and its niche is trouble falling asleep rather than staying asleep. Zaleplon has a very short elimination half-life of roughly one hour, with onset within tens of minutes, so it shortens the time needed to fall asleep (sleep latency) without reliably increasing total sleep time [1]. This ultrashort action makes it suitable for middle-of-the-night dosing when enough hours remain before waking [1]. A meta-analysis of trial data submitted to regulators found that Z drugs, including zaleplon, produced statistically significant but modest reductions in sleep latency compared with placebo, with much of the overall response attributable to placebo effects [2].
A practical advantage of its rapid clearance is a reduced burden of next-day impairment. On-the-road driving research found that, unlike benzodiazepine hypnotics and zopiclone, zaleplon did not significantly impair driving the morning after bedtime dosing, and it did not impair driving several hours after middle-of-the-night use [3]. Zaleplon is metabolized mainly by the enzyme aldehyde oxidase, with a smaller contribution from CYP3A4 [1].
Zaleplon is a controlled substance, scheduled as a Schedule IV drug in the United States and as a Class C substance in the United Kingdom, reflecting a recognized but moderate potential for misuse and dependence [1]. Like other hypnotics it can cause drowsiness, dizziness, and complex sleep behaviors, and its sedative effects are amplified by alcohol and other central nervous system depressants [1].
Mechanism
Zaleplon works as a positive modulator of the -A receptor, the principal inhibitory neurotransmitter receptor in the brain. It binds at the benzodiazepine site on the receptor and, in the presence of GABA, increases the flow of chloride ions through the receptor's channel, which hyperpolarizes neurons and dampens their activity; the net effect is sedation and a faster transition into sleep [1]. Although it is not a benzodiazepine, it therefore shares the same molecular site of action as those drugs [1].
What distinguishes zaleplon pharmacologically is a preference for -A receptors that contain the alpha-1 subunit, the subtype most closely tied to sedation and hypnosis rather than the subtypes more associated with anti-anxiety and muscle-relaxant effects [1]. This relative selectivity, together with its very short , is thought to explain why zaleplon promotes sleep onset with comparatively little disruption of normal sleep architecture and limited carryover of sedation into the next day [1][3]. Its behavioral effects fade quickly because the drug is rapidly metabolized, chiefly by aldehyde oxidase [1]. As with other -A modulators, its effects are potentiated by alcohol and other depressants, and abrupt discontinuation after regular use can be followed by rebound insomnia, although rebound appears to be relatively mild for zaleplon [1].
receptor fingerprint
-A receptor benzodiazepine sitemodulates
-A alpha-1 subunit (omega-1)agonist
-gated chloride channelactivates
-A alpha-2 and alpha-3 subunitsmodulates
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
Zaleplon is prescription only and a Schedule IV controlled substance. Common side effects include dizziness, headache, drowsiness and a lightheaded feeling. Like other Z-drugs it can trigger complex sleep behaviors such as walking, eating or even driving while not fully awake, along with short-term memory gaps. It should not be mixed with alcohol, opioids or other sedatives because breathing can slow dangerously. Cimetidine raises zaleplon levels, while strong enzyme inducers like rifampin lower them. Use caution in older adults, in liver disease and in anyone with a history of substance misuse.
Interactionsdocumented pairs only, not exhaustive
Zaleplon is metabolized by aldehyde oxidase and multiple CYP isoforms, making it less susceptible to pharmacokinetic interactions than drugs relying on a single metabolic pathway. CYP3A4 inhibitors including ketoconazole, erythromycin, and cimetidine reduce zaleplon clearance and enhance sedation (pharmacokinetic interaction); conversely, the CYP inducer rifampicin accelerates metabolism and reduces efficacy [4]. Ethanol produces additive CNS depression without altering zaleplon levels (pharmacodynamic interaction) [4]. Most anticonvulsants, other psychiatric medications, and novel agents have not been formally studied with zaleplon.
Checking a whole stack? Run it through interactions + stacks.
Subjective profileweighing the evidence above
The most sensible Z-drug for one narrow job, getting back to sleep after a middle-of-the-night waking, because it clears fast and leaves little morning fog. It can still cause sleep-walking and sleep-driving, and mixing it with alcohol is dangerous. Short-term, on prescription.
Resources
No suppliers are provided for compounds like this. This entry is here for reference.
Research
- 2003first citedClinically important drug interactions with zopiclone, zolpidem and zaleplon.
- 2025most recentClinical practice guidelines for switching or deprescribing hypnotic medications for chronic in…
- 1.Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: Results of European neuropsychopharmacology and sleep expert's consensus group.
- 2.Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration
- 3.Residual effects of sleep medication on driving ability
- 4.Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
4 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
Will zaleplon keep me asleep all night?
Not really; it is built for falling asleep. It leaves the body in a few hours, so it does little for staying asleep.
Can I take it if I wake up at 3 am?
Yes, as long as you can stay in bed at least 4 more hours, which lowers the chance of morning grogginess.
Is zaleplon addictive?
It has a lower risk than older sleeping pills but it is still a controlled medicine, so use it short term and as prescribed.
Can I drink alcohol with it?
No; combining the two deepens sedation and can slow breathing and raise the risk of sleepwalking behaviors.
Does it cause a hangover feeling?
Usually less than most sleep aids because it clears so quickly, though higher doses can still leave you foggy.
Adverse effects
- Next-day drowsiness and dizziness are possible, though usually less than with longer-acting sleeping pills
- Can cause complex sleep behaviors such as sleep-walking, sleep-eating, or sleep-driving
- Combining it with alcohol or other sedatives can cause dangerous over-sedation
- Regular use can lead to tolerance, dependence, and rebound insomnia on stopping
- Memory lapses and confusion can occur, particularly in older adults